Zdrowie i gospodarka · 23/04/1998

FDA Announces Approval of Blood Product Information Collection Under Paperwork Reduction Act

The Food and Drug Administration (FDA) has announced that it has received approval from the Office of Management and Budget (OMB) to collect information on the shipment of blood products prior to completion of testing for Hepatitis B surface antigen (HbsAg) and those known to be reactive for HbsAg, as required by the Paperwork Reduction Act of 1995 (PRA).